A case study at Clemenceau Medical Center in Beirut, Lebanon, shows that Keya Medical’s DeepVessel FFR (DVFFR) delivers results nearly identical to invasive FFR in assessing intermediate coronary artery stenosis. The findings demonstrate DVFFR’s value as a precise, non-invasive tool for guiding clinical decisions and avoiding unnecessary procedures.
Highlights from Keya Medical’s sponsored symposium “The New World of Cardiovascular Care With CCTA: Deep Learning for Ischemia & Plaque Today – What Brings Tomorrow?”
Keya Medical North America is set to enhance its presence in the United States through a series of strategic partnerships.
Watch “Bringing Cath-Lab Precision to the CT Suite: A Conversation on DeepVessel FFR”. Bayer AI Imaging TechTalk: Speaking with Keya Medical.
Recent Comments